184 related articles for article (PubMed ID: 25059524)
1. Non-clinical factors associated with TB: important for DOTS impact evaluation and disease elimination.
Hill PC; Whalen CC
Trans R Soc Trop Med Hyg; 2014 Sep; 108(9):523-5. PubMed ID: 25059524
[TBL] [Abstract][Full Text] [Related]
2. Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness.
Pantoja A; Lönnroth K; Lal SS; Chauhan LS; Uplekar M; Padma MR; Unnikrishnan KP; Rajesh J; Kumar P; Sahu S; Wares F; Floyd K
Int J Tuberc Lung Dis; 2009 Jun; 13(6):705-12. PubMed ID: 19460245
[TBL] [Abstract][Full Text] [Related]
3. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally.
Dye C; Watt CJ; Bleed DM; Hosseini SM; Raviglione MC
JAMA; 2005 Jun; 293(22):2767-75. PubMed ID: 15941807
[TBL] [Abstract][Full Text] [Related]
4. Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients.
Pantoja A; Floyd K; Unnikrishnan KP; Jitendra R; Padma MR; Lal SS; Uplekar M; Chauhan LS; Kumar P; Sahu S; Wares F; Lönnroth K
Int J Tuberc Lung Dis; 2009 Jun; 13(6):698-704. PubMed ID: 19460244
[TBL] [Abstract][Full Text] [Related]
5. Tuberculosis elimination: where are we now?
Matteelli A; Rendon A; Tiberi S; Al-Abri S; Voniatis C; Carvalho ACC; Centis R; D'Ambrosio L; Visca D; Spanevello A; Battista Migliori G
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29898905
[TBL] [Abstract][Full Text] [Related]
6. Working towards TB elimination the WHO Regional Strategic Plan (2006-2015).
Nair N; Cooreman E
J Commun Dis; 2006 Mar; 38(3):185-90. PubMed ID: 17373351
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis control: current status, challenges and barriers ahead in 22 high endemic countries.
Ibrahim KM; Khan S; Laaser U
J Ayub Med Coll Abbottabad; 2002; 14(4):11-5. PubMed ID: 12688094
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of different treatment strategies for tuberculosis in Egypt and Syria.
Vassall A; Bagdadi S; Bashour H; Zaher H; Maaren PV
Int J Tuberc Lung Dis; 2002 Dec; 6(12):1083-90. PubMed ID: 12546116
[TBL] [Abstract][Full Text] [Related]
9. Progress towards tuberculosis elimination in Cuba.
González E; Armas L; Llanes MJ
Int J Tuberc Lung Dis; 2007 Apr; 11(4):405-11. PubMed ID: 17394686
[TBL] [Abstract][Full Text] [Related]
10. The Innovative Socio-economic Interventions Against Tuberculosis (ISIAT) project: an operational assessment.
Rocha C; Montoya R; Zevallos K; Curatola A; Ynga W; Franco J; Fernandez F; Becerra N; Sabaduche M; Tovar MA; Ramos E; Tapley A; Allen NR; Onifade DA; Acosta CD; Maritz M; Concha DF; Schumacher SG; Evans CA
Int J Tuberc Lung Dis; 2011 Jun; 15 Suppl 2(Suppl 2):50-57. PubMed ID: 21740659
[TBL] [Abstract][Full Text] [Related]
11. The long-term health and economic benefits of DOTS implementation in Ecuador.
Oxlade O; Vaca J; Romero E; Schwartzman K; Graham B; Hernandez L; Tannenbaum T; Menzies D
Can J Public Health; 2006; 97(1):14-9. PubMed ID: 16512320
[TBL] [Abstract][Full Text] [Related]
12. Cash transfer and microfinance interventions for tuberculosis control: review of the impact evidence and policy implications.
Boccia D; Hargreaves J; Lönnroth K; Jaramillo E; Weiss J; Uplekar M; Porter JDH; Evans CA
Int J Tuberc Lung Dis; 2011 Jun; 15 Suppl 2(Suppl 2):37-49. PubMed ID: 21740658
[TBL] [Abstract][Full Text] [Related]
13. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
Pablos-Mendez A; Gowda DK; Frieden TR
Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
[TBL] [Abstract][Full Text] [Related]
14. Scenario Analysis for Programmatic Tuberculosis Control in Western Province, Papua New Guinea.
Trauer JM; Denholm JT; Waseem S; Ragonnet R; McBryde ES
Am J Epidemiol; 2016 Jun; 183(12):1138-48. PubMed ID: 27199387
[TBL] [Abstract][Full Text] [Related]
15. DOTS expansion: will we reach the 2005 targets?
Véron LJ; Blanc LJ; Suchi M; Raviglione MC
Int J Tuberc Lung Dis; 2004 Jan; 8(1):139-46. PubMed ID: 14974757
[TBL] [Abstract][Full Text] [Related]
16. [Reform of Japan's NTP and its technical perspectives].
Mori T
Kekkaku; 2004 Oct; 79(10):587-604. PubMed ID: 15631111
[TBL] [Abstract][Full Text] [Related]
17. Response to a major disease of poverty: the Global Partnership to Stop TB.
Lee JW; Loevinsohn E; Kumaresan JA
Bull World Health Organ; 2002; 80(6):428. PubMed ID: 12131996
[No Abstract] [Full Text] [Related]
18. Can IMA-RNTCP stop TB by 2050?
Sisodia RS; Jain DK; Agarwal SS; Gupta A
J Indian Med Assoc; 2011 Oct; 109(10):742, 747-50. PubMed ID: 22482323
[TBL] [Abstract][Full Text] [Related]
19. Tuberculosis-a World Health Organization Perspective.
Sotgiu G; Sulis G; Matteelli A
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28185618
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
